Shared Decision Making in Early-Stage Non-small Cell Lung Cancer: A Systematic Review

Dalmia, Sanjush; Boele, Florien; Absolom, Kate; Brunelli, Alessandro; Franks, K.; Bekker, Hilary; Pompili, Cecilia

doi:10.1016/j.athoracsur.2021.01.046

Cited by 8 publications

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients discussed at MDT meeting were significantly more likely to receive curative treatment compared to those who were not [59] . Clinicians’ biases, referral practices and attitudes towards radiotherapy have also been shown to influence utilisation rates [60] , [61] , [62] . Moreover, patients’ travel distance to the nearest centre strongly predicted the rates of undergoing SABR, as 45% of untreated stage I NSCLC would have had to travel around 45 min to the nearest centre [36] .…”

Section: Discussionmentioning

confidence: 99%

Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia

Ghandourh

Holloway

Batumalai

et al. 2022

Clinical and Translational Radiation Oncology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia

Ghandourh

Holloway

Batumalai

et al. 2022

Clinical and Translational Radiation Oncology

View full text Add to dashboard Cite

“…It is based on ‘what matters’ to them and their individual strengths and needs. The availability of PROMs data helps clinicians to communicate the benefits and the risks of a treatment, giving the patient a clearer overview of potential alternatives tailored for his/her individual, which has been demonstrated to be rarely discussed in lung cancer care [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

The role of patient-reported outcome and experience measures in cardio-thoracic surgery

Pompili,

Scheenstra,

Zirafa

et al. 2024

Interdisciplinary CardioVascular and Thoracic Surgery

Self Cite

View full text Add to dashboard Cite

“…Moreover, both patients and clinicians prefer adopting a collaborative role in treatment decisions. In previous studies of patients with early-stage cancer, most patients stated that they did not remember having to choose a treatment modality and experienced little or no decision-making conflict (12), preferred playing an active or cooperative role with their caregivers in treatment decision-making, and found it important to discuss and share their opinions/decisions with their caregivers (13). Thus, to provide effective decision support, it is necessary to understand the factors that influence the patient's decision-making process.…”

mentioning

confidence: 99%

Factors Involved in Shared Decision-making Regarding Treatment Selection by Patients With Cancer

KAWASAKI,

HIRAI,

NII

et al. 2024

CDP

View full text Add to dashboard Cite

Background/Aim: Patients diagnosed with cancer are expected to choose one or more treatment modalities after receiving corresponding explanations of the options. When making these choices, patients consider the effects of treatment and aspects related to their quality of life. These concerns can cause confusion and conflict owing to the complicated information provided by medical caregivers. The objective of the study was to identify perceptions of cancer treatment in patients with cancer and the decision-making factors affecting their treatment choices. Patients and Methods: In this observational (cross-sectional) study, an online questionnaire survey was administered to 194 Japanese cancer patients with treatment experience. Patient information, perceptions of explanations provided by healthcare professionals, treatment views, and reasons for treatment decisions were subjected to a simple tabulation. Content and factor analysis was conducted to determine important treatment selection elements. Results: Regarding treatment perception, 60.3% of respondents (n=117) considered treatment a financial and family burden, 47.4% (n=92) had concerns about physical pain, and 40.2% (n=78) were worried about increased stress. Regarding decision-making quality, 95.9% determined their preferred treatment within one week, 49.0% reported difficulties in making their decisions, and 83.0% chose their treatment themselves. Major decisive factors were prolonging life, opinions of medical staff, and accepting treatment risks (68.0%, 68.6%, and 60.3% of patients, respectively). The main attitudes toward treatment were anxiety, expectations of benefit, and expectations of support and care. Conclusion: SDM should enable patients to visualize the changes that their bodies will experience and include discussions on prognosis. Psychological care should be prioritized to alleviate anxiety and improve readiness for decision-making; attention should be paid to the extent and timing of information provision.

show abstract

Shared Decision Making in Early-Stage Non-small Cell Lung Cancer: A Systematic Review

Cited by 8 publications

References 39 publications

Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia

Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia

The role of patient-reported outcome and experience measures in cardio-thoracic surgery

Factors Involved in Shared Decision-making Regarding Treatment Selection by Patients With Cancer

Contact Info

Product

Resources

About